Application of recombinant human calcineurin B subunit

A technology of loading and drug administration, applied in the field of protein, can solve the problem of no killing or inhibition of gastric cancer cells MGC-803

Active Publication Date: 2016-03-30
HAIKOU QILI PHARMA
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] However, there are no relevant reports on the killing or inhibiting effect of rhCNB on gastric cancer cell line MGC-803

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of recombinant human calcineurin B subunit
  • Application of recombinant human calcineurin B subunit
  • Application of recombinant human calcineurin B subunit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1B

[0035] Example 1 Establishment of BALB / c Nude Mice Bearing Human Gastric Cancer Cell MGC-803 Subcutaneously Transplanted Tumor Model

[0036] Human gastric cancer cell MGC-803 was routinely cultured in vitro, digested and centrifuged to make a concentration of about 1×10 7 1 cell / mL cell suspension, 0.2 mL / only was inoculated subcutaneously in the right axilla of the mouse.

Embodiment 2B

[0037] Example 2 Establishment of BALB / c Nude Mice Bearing Human Gastric Cancer Cell MGC-803 Orthotopic Transplantation Model

[0038] The well-grown subcutaneous xenografts were taken out and cut into tumor tissue pieces about 2×2×1 mm in size for later use. The animals to be inoculated were gas anesthetized with isoflurane and fed for 12 hours before the operation. After the animal is anesthetized, take the supine position, cut the skin horizontally layer by layer on the left side at 2-5 mm below the xiphoid process, and open about 1 cm, gently pull out the stomach with small forceps to expose it, and use 1# surgical thread to cut the tumor tissue "Purse-string suture" was performed on the side of the greater curvature of the stomach of nude mice near the door, and the tumor tissue was wrapped in it, and the skin was sutured layer by layer, and put back into the cage for normal feeding. Seven days after the operation, detection, grouping and drug administration were perform...

Embodiment 3

[0039] Embodiment 3 animal grouping

[0040] Take 90 inoculated nude mice and randomly divide them into rhCNB high-dose group for injection, rhCNB middle-dose group for injection, rhCNB low-dose group for injection, rhCNB dose-increasing group for injection and positive control rhCNB injection group according to bioluminescence detection data. Recombinant human interleukin-2 administration group, positive control cisplatin high-dose injection group, positive control cisplatin low-dose injection group, positive control hydroxycamptothecin injection group and vehicle control group Group, 10 in each group.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of proteins, in particular to application of recombinant human calcineurin B subunit, and mainly provides application of rhCNB to preparation of a medicine for killing and / or inhibiting a gastric cancer cell MGC-803. When rhCNB for injection plays a role in treatment of human gastric cancer cell MGC-803 carcinoma in situ transplantation tumors in BALB / c nude mice, the effective tumor treatment (compared with that of a solvent control group, p is smaller than 0.05) time starts after continuous medication for 6 times; in the whole medication process, the tumors can be effectively controlled; one week after medicine withdrawal, rhCNB for injection still has a continuous and effective treating effect (compared with that of the solvent control group, p is smaller than 0.001) on the tumors; the performance of rhCNB for injection is superior to those of cisplatin for positive control injection and hydroxycamptothecine for injection, and equivalent to recombinant human interleukin-2 for injection.

Description

technical field [0001] The invention relates to the protein field, in particular to the application of recombinant human calmodulin phosphatase B subunit. Background technique [0002] Calcineurin (CN) is the only known Ca-dependent 2+ / CaM (calmodulin) protein phosphatase, composed of A, B subunits in a 1:1 ratio. The A subunit (CNA) is the catalytic subunit and the B subunit (CNB) is the regulatory subunit. CN plays an important role in the immune activation pathway and is a key enzyme for T cell activation. As a macromolecular enzyme protein, CN is easily inactivated and unstable, while CNB, as the regulatory subunit of the enzyme, can promote the activity of CNA, and has a small relative molecular mass and stable properties. Studies have shown that CNB can stimulate the proliferation of T cells and NK cells, enhance the killing activity of NK cells, enhance the phagocytosis of macrophages and other immune functions, and the recombinant human Calcineurin B subunit (rhC...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/46A61P35/00
CPCA61K9/0019A61K38/465C12Y301/03016A61K9/08A61P35/04
Inventor 韩克胜符健黄宗文田树红韩丽芳
Owner HAIKOU QILI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap